Skip to content

The Ethically Challenged: How Pharma Fares

070603_pharmalot2.jpgIn these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and charts by collecting reports – both positive and negative recent news – from the Internet and an ‘open network of correspondents’ among various civil-society groups, researchers, consultants and the like. The data is then coded, quantified and synthetized into curves and volumes. The rankings are, of course, relative. They merely compare drugmakers to one another and don’t examine ethics in absolute terms. In other words, company A is perceived as more ethical than company B, but that’s not the same thing as saying one or both companies are, or aren’t, particularly adept at adopting and exercising ethical practices.

Publication about Covalence | Country: Global | Company: GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, Novartis, Pfizer, Roche, Abbott, Boehringer-Ingelheim, Merck & Co, Eli Lilly, Sanofi-Aventis | Source: Pharmalot

Back To Top